US OptionsDetailed Quotes
RMTI250117C5000
- 0.05
- 0.000.00%
15min DelayClose Jan 14 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume8 Open Interest5.00Strike Price0.00Turnover663.63%IV152.50%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1090Delta0.1561Gamma40.00Leverage Ratio-0.0325Theta0.0000Rho4.36Eff Leverage0.0003Vega
Rockwell Medical Stock Discussion
I'm gonna pull out with a 3% stop-loss. Their initiatives are more long-term, and that revenue dip is gonna cause price to plummet. I'll keep an eye on them, mayb see where they at in a few quarters.
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
$KULR Technology (KULR.US)$ PR 12/17: Signs Service Agreement to Launch KULR ONE Space Battery. COH $13.4M good for 9 months✅
$Wearable Devices (WLDS.US)$ PR 12/17:...
Rockwell Medical Enters Into a Multi-Year Product Purchase Agreement With the World's Leading Provider of Dialysis Products and Services! Partnership is expected to generate upwards of $10 million in net sales for the Company in 2025, with incremental price increases each subsequent year and an effective term of up to five years
Benzinga· 5 mins ago
Rockwell anticipates that with these new mixer installations through HydroCare, the Company will also generate new sales related to its dry acid hemodialysis concentrates. Rockwell Medical's DAMX45 dry acid concentrate mix system is 510(k) approved to be used exclusively with the Company's CitraPure and ...
Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System
Rockwell Medical (RMTI) has announced a partnership with HydroCare, a provider of dialysis water treatment systems, to distribute and install Rockwell's dry acid concentrate mix system in dialysis water rooms. The partnership involves HydroCare purchasing and installing Rockwell's DAMX45 system, which is 510(k) approved for exclusive use with the company's CitraP...
Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter
Rockwell Medical (RMTI) reported strong Q3 2024 financial results with net product sales of $28.3 million, up 31% year-over-year.
The company achieved gross profit of $6.2 million (183% increase) and a gross margin of 22%.
Notable highlights include $4.3 million in cash flow from operations and net income of...
No comment yet